Juan Estruch
About Juan Estruch
Head of Corporate Development Juan Estruch
Juan Estruch serves as the Head of Corporate Development, leveraging over 25 years of experience in the Life Sciences sector. His role focuses primarily on strategic planning and identifying new growth opportunities for the organizations he works with. Estruch co-founded Secura Bio, demonstrating his commitment to advancing the biopharmaceutical field. His expertise includes product assessment and corporate strategy, which have been pivotal in his leadership roles.
Juan Estruch's Extensive Experience in Life Sciences
With over 25 years in the Life Sciences industry, Juan Estruch has accumulated extensive experience. He has held senior positions in prominent companies such as Ciba-Geigy, Novartis, Diversa, Prometheus, and Genoptix. His career is marked by a strong track record in product assessment, corporate strategy, and corporate development, making significant contributions in each role he has undertaken.
Juan Estruch's Key Roles in Major Biopharmaceutical Companies
Juan Estruch has served in senior positions or as head of corporate development for several major biopharmaceutical companies. These include Ciba-Geigy, Novartis, Diversa, Prometheus, and Genoptix. His work in these firms has established him as a key player in the industry, particularly in identifying and leveraging under-exploited biopharmaceutical assets for repositioning or relaunching.
Juan Estruch's Educational Background
Juan Estruch holds a Ph.D. in Biochemistry and Molecular Biology, earned from the University of Essen, Germany and Valencia, Spain. Complementing his scientific expertise, Estruch also earned an MBA from the Fuqua School of Business, Duke University. This combination of advanced scientific training and business acumen equips him with a unique perspective in the Life Sciences sector.
Co-Founding of Secura Bio by Juan Estruch
Juan Estruch co-founded Secura Bio, contributing to the company's strategic direction and growth. His role in the company underscores his dedication to the biopharmaceutical industry and highlights his capacity for innovation and leadership. Under his co-founding guidance, Secura Bio aims to address unmet needs in the market through the development and repositioning of biopharmaceutical assets.